Real-Life and RCT Participants: Alendronate Users Versus FITs' Trial Eligibility Criterion

Carlen Reyes, Anton Pottegård, Peter Schwarz, M Kassim Javaid, Tjeerd P. van Staa, Cyrus Cooper, Adolfo Diez-Perez, Bo Abrahamsen, Daniel Prieto-Alhambra